Ara
Toplam kayıt 12, listelenen: 1-10
Evaluation of the Methods Used for the Vital Signs Measurement in Hospitalized Patients
(2018)
In general, vital signs measurements which includes measurement of blood pressure, body temperature, pulse and oxygen levels provide very important information about the health status of the hospitalized patients and the ...
Economic Burden of Pediatric Asthma in Turkey: A Cost of Illness Study from Payer Perspective
(2020)
OBJECTIVES: To estimate economic burden of pediatric asthma in Turkey from payer perspective.
MATERIALS AND METHODS: This cost of illness study was based on identification of per patient annual direct medical costs for ...
The impact of addressing modifiable risk factors to reduce the burden of cardiovascular disease in Turkey
(2019)
Objective: Our study aimed to estimate the impact of addressing modifiable risk factors on the future burden of cardiovascular diseases (CVD) in the general population and in two high-risk populations (heterozygous familial ...
Cost of illness among patients with diabetic foot ulcer in Turkey
(2016)
AIM
To evaluate the annual cost of patients with Wagner grade 3-4-5 diabetic foot ulcer (DFU) from the public payer's perspective in Turkey.
METHODS
This study was conducted focused on a time frame of one year ...
Patient Characteristics And Management Practices In Chronic Myeloid Leukemia In Turkey: Reflections From An Expert Meeting
(2022)
Introduction The therapeutic landscape of chronic myeloid leukemia (CML) has evolved significantly since the introduction of imatinib. The European LeukemiaNet (ELN) recommendations serve as a guide for diagnosis, treatment, ...
Assessment of the Direct Medical Costs of Type 2 Diabetes Mellitus and its Complications in Turkey
(2014)
Purpose: To estimate the direct annual medical costs of Type 2 diabetes and its complications in diagnosed patients in Turkey.
Material and Method: A cost-of-illness model was developed. The prevalence of Type 2 diabetes ...
Efficacy and Cost-Effectivity Analysis of Outpatient Parenteral Antimicrobial Therapy Unit in Infectious Disease Clinical Practices: Turkey Perspective
(2021)
Background Outpatient parenteral antimicrobial treatment (OPAT) has become a common treatment modality in developed countries. OPAT units are not widespread in Turkey, and their cost-effectivity analysis has not been ...
Economic Burden Of Lung Cancer In Turkey: A Cost Of Illness Study From Payer Perspective
(2021)
Background This study was designed to estimate economic burden of lung cancer in Turkey from payer perspective based on expert panel opinion on practice patterns in clinical practice. Methods In this cost of illness study, ...
Cost-Effectiveness Analysis of Remdesivir Treatment in COVID-19 Patients Requiring Low-Flow Oxygen Therapy: Payer Perspective in Turkey
(2021)
Introduction This study aims to evaluate the cost-effectiveness of remdesivir compared to other existing therapies (SoC) in Turkey to treat COVID-19 patients hospitalized with < 94% saturation and low-flow oxygen therapy ...
COVID-19 healthcare cost and length of hospital stay in Turkey: retrospective analysis from the first peak of the pandemic
(2021)
Background During the COVID-19 pandemic, health care systems are under extreme pressure. This study analyzed health care resource use (HCRU) and costs in patients admitted to the hospital for COVID-19 and aimed to estimate ...